Guide: A comprehensive overview of the autoimmunity world
Discover the possibilities opened up by HTRF cytokine assays in an autoimmune context.
List view / Grid view
Discover the possibilities opened up by HTRF cytokine assays in an autoimmune context.
The essential guide for extending your knowledge on the molecular mechanisms of neurodegenerative diseases
This review highlights five recent publications about homogeneous assays applied to PROTACs, a chemical knockdown approach for cancer research.
The number of immuno-oncology active agents has seen a tremendous boost during the past three years. The 2019 global immuno-oncology pipeline consists of almost 3,900 agents, making immuno-oncology discovery very attractive.
A global general immunology guide delivering the fundamentals of innate and adaptive immunity, including the description of immune cell types and their associated signaling pathways
The landscape of cancer treatment has changed dramatically in the last seven years, beginning with the approval of Ipilmumab in 2011, the first immunotherapy drug. Efforts to unsheathe the tumour cells of their protective microenvironment and expose them to an active immune response have delivered several monoclonal antibodies (mAbs) that…
This new guide reviewing the material and methods with HTRF® Toolbox reagents is for you...
4 October 2016 | By Cisbio
Cisbio Bioassays has developed several assays for covering all the needs for monitoring kinase targets...
4 October 2016 | By Cisbio
A comprehensive line of ready-to-use HTRF toolbox reagents labeled with HTRF fluorescent dyes for studying molecular interactions using time-resolved fluorescence energy transfer...
4 October 2016 | By Cisbio
Rapid advancements have been made in understanding the key role epigenetic modifications play in regulating cell activity and their implications on cell health and disease progression...
4 October 2016 | By Cisbio
HTRF® cellular phospho-/total protein assays provide precise, sensitive measurement of endogeneous levels of phosphorylated and non phophorylated proteins able to be achieved in an endogenous cellular environment...
4 October 2016 | By Cisbio Bioassays
A line of high quality products have been developed, addressing biomarkers to meet the needs of multiple therapeutic areas such as inflammation, oncology, metabolic disease or CNS...
3 October 2016 | By Cisbio Bioassays
Cisbio Bioassays has supported GPCR investigation for many years regularly creating cutting edge assays and technologies suited to receptor characterization, compound screening and lead optimization...
Cisbio Bioassays has developed a GPCR platform based on the company’s HTRF® technology to measure second messenger accumulation...